Time course of changes in oxygen saturation (A), respiratory rate (B), and heart rate (C) after monocrotaline injection and representative data during oxygen therapy (D). Oxygen therapy was initiated 17 days after monocrotaline injection. MCT O2, monocrotaline injection with oxygen therapy (total n = 9; 15–19 days, n = 9; 20 day, n = 7; 21 day, n = 2); MCT non-O2, monocrotaline injection without oxygen therapy (total n = 9; 15–17 days, n = 9; 18–21 days, n = 8). The data are shown as the mean ± standard deviation. *Significantly different from the MCT non-O2 group by independent t-test, p < 0.05.</p
Pulmonary arterial hypertension (PAH) is a rare, progressive, and fatal cardiovascular/lung disease....
Abstract Pulmonary hypertension (PH) is a global health issue with a prevalence of 10% in ages >65 y...
<p>(A) Schematic PH model protocols for control, chronic hypoxia (CH), monocrotaline (MCT), and comb...
Survival rate (A) and body weight (B) after monocrotaline injection. Oxygen therapy was initiated 17...
Although oxygen therapy rapidly improves arterial oxygen saturation in idiopathic pulmonary arterial...
1. This study investigates the time course of pulmonary arterial hypertension (PAH) due to monocrota...
<p><b>(a)</b> MCT was injected at a dose of 60 mgkg<sup>-1</sup> i.p. on day 1. Fourteen days (washo...
Monocrotaline is a pyrrolizidine alkaloid found in plants implicated in livestock and human poisonin...
Representative transverse sections of pulmonary arterioles stained with Elastica van Gieson (A). MCT...
Pulmonary hypertension (PH) is a life-threatening disease with unclear vascular mechanisms. We teste...
Pulmonary hypertension is called PH for short. It is caused by the pulmonary artery vascular disease...
A close relationship exists between hypoxia-inducible factor (HIF)-1alpha and pulmonary hypertension...
<p>(<b>A</b>) Pulmonary arterial acceleration time/right ventricular ejection time (PAAT/RVET). Repr...
Superoxide dismutase (SOD) activity (A), protein carbonyl content (B), expression level of nicotinam...
Pulmonary hypertension (PH) is an incurable condition inevitably resulting in death because of incre...
Pulmonary arterial hypertension (PAH) is a rare, progressive, and fatal cardiovascular/lung disease....
Abstract Pulmonary hypertension (PH) is a global health issue with a prevalence of 10% in ages >65 y...
<p>(A) Schematic PH model protocols for control, chronic hypoxia (CH), monocrotaline (MCT), and comb...
Survival rate (A) and body weight (B) after monocrotaline injection. Oxygen therapy was initiated 17...
Although oxygen therapy rapidly improves arterial oxygen saturation in idiopathic pulmonary arterial...
1. This study investigates the time course of pulmonary arterial hypertension (PAH) due to monocrota...
<p><b>(a)</b> MCT was injected at a dose of 60 mgkg<sup>-1</sup> i.p. on day 1. Fourteen days (washo...
Monocrotaline is a pyrrolizidine alkaloid found in plants implicated in livestock and human poisonin...
Representative transverse sections of pulmonary arterioles stained with Elastica van Gieson (A). MCT...
Pulmonary hypertension (PH) is a life-threatening disease with unclear vascular mechanisms. We teste...
Pulmonary hypertension is called PH for short. It is caused by the pulmonary artery vascular disease...
A close relationship exists between hypoxia-inducible factor (HIF)-1alpha and pulmonary hypertension...
<p>(<b>A</b>) Pulmonary arterial acceleration time/right ventricular ejection time (PAAT/RVET). Repr...
Superoxide dismutase (SOD) activity (A), protein carbonyl content (B), expression level of nicotinam...
Pulmonary hypertension (PH) is an incurable condition inevitably resulting in death because of incre...
Pulmonary arterial hypertension (PAH) is a rare, progressive, and fatal cardiovascular/lung disease....
Abstract Pulmonary hypertension (PH) is a global health issue with a prevalence of 10% in ages >65 y...
<p>(A) Schematic PH model protocols for control, chronic hypoxia (CH), monocrotaline (MCT), and comb...